Corvus Pharmaceuticals, Inc. · NASDAQ:CRVS
The Vanguard Group reported a 5.18% stake in Corvus Pharmaceuticals, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Jan 30, 2026
The Vanguard Group reported a 5.18% stake in Corvus Pharmaceuticals, Inc., 3,873,482 shares, as a passive investor on Dec 31, 2025. Filed Jan 30, 2026 (Schedule 13G).
- Stake
- 5.18%
- Shares
- 3,873,482
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 5.18% | 3,873,482 |
Source
Related
- Corvus Pharmaceuticals, Inc.
- The Vanguard Group
- Corvus Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Moore David Scott · Jun 15, 2026
- Form 4 · Miller Richard A Md · May 20, 2026
- Schedule 13G · Sirenia Capital Management LP · May 15, 2026